Display Settings:

Format

Send to:

Choose Destination
Transplant Proc. 2000 May;32(3):596.

A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients.

Author information

  • 1Bone Marrow Transplantation Unit, Nemazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
PMID:
10812128
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk